Clemens Decristoforo (C Decristoforo)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 44

Top Venues

EJNMMI radiopharmacy and chemistry

Pharmaceuticals (Basel, Switzerland)

Journal of medicinal chemistry

Journal of fungi (Basel, Switzerland)

Tirol Kliniken

Leopold Franzens Universität für Innsbruck (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tirol Kliniken Feb 04 1991

Austria

Radiopharmacist :: Nuclear Medicine

Education History

Leopold Franzens Universität für Innsbruck Oct 01 1991

Austria

PHD

Leopold Franzens Universität für Innsbruck Jan 10 1983 - Feb 04 1991

Austria

MSC

Publications

Andrzej Mular, Isabella Hubmann, Milos Petrik, Katerina Bendova, Barbora Neuzilova, Mario Aguiar, Patricia Caballero, Abraham Shanzer, Henryk Kozłowski, Hubertus Haas, Clemens Decristoforo, Elzbieta Gumienna-Kontecka
Biomimetic Analogues of the Desferrioxamine E Siderophore for PET Imaging of Invasive Aspergillosis: Targeting Properties and Species Specificity. Journal of medicinal chemistry 67 (14) (2024)
Andrzej Mular, Isabella Hubmann, Milos Petrik, Katerina Bendova, Barbora Neuzilova, Mario Aguiar, Patricia Caballero, Abraham Shanzer, Henryk Kozłowski, Hubertus Haas, Clemens Decristoforo, Elzbieta Gumienna-Kontecka
Biomimetic Analogues of the Desferrioxamine E Siderophore for PET Imaging of Invasive Aspergillosis: Targeting Properties and Species Specificity. Journal of medicinal chemistry (2024)
Andrzej Mular, Isabella Hubmann, Milos Petrik, Katerina Bendova, Barbora Neuzilova, Mario Aguiar, Patricia Caballero, Abraham Shanzer, Henryk Kozłowski, Hubertus Haas, Clemens Decristoforo, Elzbieta Gumienna-Kontecka
Biomimetic Analogues of the Desferrioxamine E Siderophore for PET Imaging of Invasive Aspergillosis: Targeting Properties and Species Specificity. Journal of medicinal chemistry 67 (14) (2024)
Andrzej Mular, Isabella Hubmann, Milos Petrik, Katerina Bendova, Barbora Neuzilova, Mario Aguiar, Patricia Caballero, Abraham Shanzer, Henryk Kozłowski, Hubertus Haas, Clemens Decristoforo, Elzbieta Gumienna-Kontecka
Biomimetic Analogues of the Desferrioxamine E Siderophore for PET Imaging of Invasive Aspergillosis: Targeting Properties and Species Specificity. Journal of medicinal chemistry 67 (14) (2024)
Aruna Korde, Marianne Patt, Svetlana V Selivanova, Andrew M Scott, Rolf Hesselmann, Oliver Kiss, Natesan Ramamoorthy, Sergio Todde, Sietske M Rubow, Luther Gwaza, Serge Lyashchenko, Jan Andersson, Brian Hockley, Ravindra Kaslival, Clemens Decristoforo
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Aruna Korde, Marianne Patt, Svetlana V Selivanova, Andrew M Scott, Rolf Hesselmann, Oliver Kiss, Natesan Ramamoorthy, Sergio Todde, Sietske M Rubow, Luther Gwaza, Serge Lyashchenko, Jan Andersson, Brian Hockley, Ravindra Kaslival, Clemens Decristoforo
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Andrzej Mular, Isabella Hubmann, Milos Petrik, Katerina Bendova, Barbora Neuzilova, Mario Aguiar, Patricia Caballero, Abraham Shanzer, Henryk Kozłowski, Hubertus Haas, Clemens Decristoforo, Elzbieta Gumienna-Kontecka
Biomimetic Analogues of the Desferrioxamine E Siderophore for PET Imaging of Invasive Aspergillosis: Targeting Properties and Species Specificity. Journal of medicinal chemistry 67 (14) (2024)
Aruna Korde, Marianne Patt, Svetlana V Selivanova, Andrew M Scott, Rolf Hesselmann, Oliver Kiss, Natesan Ramamoorthy, Sergio Todde, Sietske M Rubow, Luther Gwaza, Serge Lyashchenko, Jan Andersson, Brian Hockley, Ravindra Kaslival, Clemens Decristoforo
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Aruna Korde, Marianne Patt, Svetlana V Selivanova, Andrew M Scott, Rolf Hesselmann, Oliver Kiss, Natesan Ramamoorthy, Sergio Todde, Sietske M Rubow, Luther Gwaza, Serge Lyashchenko, Jan Andersson, Brian Hockley, Ravindra Kaslival, Clemens Decristoforo
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Aruna Korde, Marianne Patt, Svetlana V Selivanova, Andrew M Scott, Rolf Hesselmann, Oliver Kiss, Natesan Ramamoorthy, Sergio Todde, Sietske M Rubow, Luther Gwaza, Serge Lyashchenko, Jan Andersson, Brian Hockley, Ravindra Kaslival, Clemens Decristoforo
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Volker Morath, Corinna Brandt, Friedrich-Christian Deuschle, Claudia T Mendler, Birgit Blechert, Dominik Summer, Cyril Barinka, Clemens Decristoforo, Wolfgang A Weber, Markus Schwaiger, Arne Skerra
Molecular Design of 68 Ga- and 89 Zr-Labeled Anticalin Radioligands for PET-Imaging of PSMA-Positive Tumors. Molecular pharmaceutics (2023)
Martin Kraihammer, Piotr Garnuszek, Andreas Bauman, Michael Maurin, Manuel Alejandre Lafont, Roland Haubner, Elisabeth von Guggenberg, Michael Gabriel, Clemens Decristoforo
Improved quality control of [ 177 Lu]Lu-PSMA I&T. EJNMMI radiopharmacy and chemistry 8 (1) (2023)
Doroteja Novak, Barbara Janota, Anton Amadeus Hörmann, Agnieszka Sawicka, Marko Kroselj, Alicja Hubalewska-Dydejczyk, Melpomeni Fani, Renata Mikolajczak, Petra Kolenc, Clemens Decristoforo, Piotr Garnuszek
Development of the 99m Tc-Labelled SST 2 Antagonist TECANT-1 for a First-in-Man Multicentre Clinical Study. Pharmaceutics 15 (3) (2023)
Doroteja Novak, Barbara Janota, Anton Amadeus Hörmann, Agnieszka Sawicka, Marko Kroselj, Alicja Hubalewska-Dydejczyk, Melpomeni Fani, Renata Mikolajczak, Petra Kolenc, Clemens Decristoforo, Piotr Garnuszek
Development of the 99m Tc-Labelled SST 2 Antagonist TECANT-1 for a First-in-Man Multicentre Clinical Study. Pharmaceutics 15 (3) (2023)
Martin Kraihammer, Piotr Garnuszek, Andreas Bauman, Michael Maurin, Manuel Alejandre Lafont, Roland Haubner, Elisabeth von Guggenberg, Michael Gabriel, Clemens Decristoforo
Improved quality control of [ 177 Lu]Lu-PSMA I&T. EJNMMI radiopharmacy and chemistry 8 (1) (2023)
Martin Kraihammer, Piotr Garnuszek, Andreas Bauman, Michael Maurin, Manuel Alejandre Lafont, Roland Haubner, Elisabeth von Guggenberg, Michael Gabriel, Clemens Decristoforo
Improved quality control of [ 177 Lu]Lu-PSMA I&T. EJNMMI radiopharmacy and chemistry 8 (1) (2023)
Martin Kraihammer, Piotr Garnuszek, Andreas Bauman, Michael Maurin, Manuel Alejandre Lafont, Roland Haubner, Elisabeth von Guggenberg, Michael Gabriel, Clemens Decristoforo
Improved quality control of [ 177 Lu]Lu-PSMA I&T. EJNMMI radiopharmacy and chemistry 8 (1) (2023)
Doroteja Novak, Barbara Janota, Anton Amadeus Hörmann, Agnieszka Sawicka, Marko Kroselj, Alicja Hubalewska-Dydejczyk, Melpomeni Fani, Renata Mikolajczak, Petra Kolenc, Clemens Decristoforo, Piotr Garnuszek
Development of the 99m Tc-Labelled SST 2 Antagonist TECANT-1 for a First-in-Man Multicentre Clinical Study. Pharmaceutics 15 (3) (2023)
Aruna Korde, Renata Mikolajczak, Petra Kolenc, Penelope Bouziotis, Hadis Westin, Mette Lauritzen, Michel Koole, Matthias Manfred Herth, Manuel Bardiès, Andre F Martins, Antonio Paulo, Serge K Lyashchenko, Sergio Todde, Sangram Nag, Efthimis Lamprou, Antero Abrunhosa, Francesco Giammarile, Clemens Decristoforo
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals. EJNMMI radiopharmacy and chemistry 7 (1) (2022)
Leonhard Gruber, Clemens Decristoforo, Christian Uprimny, Peter Hohenberger, Stefan O Schoenberg, Francesca Orlandi, Maurizio Franco Mariani, Claudia Manzl, Maria Theresia Kasseroler, Herbert Tilg, Bettina Zelger, Werner R Jaschke, Irene J Virgolini
Imaging Properties and Tumor Targeting of 68 Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients. Biomedicines 10 (11) (2022)
Anton A Hörmann, Maximilian Klingler, Christine Rangger, Christian Mair, Clemens Decristoforo, Christian Uprimny, Irene J Virgolini, Elisabeth von Guggenberg
Radiopharmaceutical Formulation and Preclinical Testing of 68Ga-Labeled DOTA-MGS5 for the Regulatory Approval of a First Exploratory Clinical Trial. Pharmaceuticals (Basel, Switzerland) 14 (6) (2021)
Joachim Pfister, Milos Petrik, Katerina Bendova, Barbara Matuszczak, Ulrike Binder, Matthias Misslinger, Alexander Kühbacher, Fabio Gsaller, Hubertus Haas, Clemens Decristoforo
Antifungal Siderophore Conjugates for Theranostic Applications in Invasive Pulmonary Aspergillosis Using Low-Molecular TAFC Scaffolds. Journal of fungi (Basel, Switzerland) 7 (7) (2021)
Andrzej Mular, Abraham Shanzer, Henryk Kozłowski, Isabella Hubmann, Matthias Misslinger, Julia Krzywik, Clemens Decristoforo, Elzbieta Gumienna-Kontecka
Cyclic Analogs of Desferrioxamine E Siderophore for 68Ga Nuclear Imaging: Coordination Chemistry and Biological Activity in Staphylococcus aureus. Inorganic chemistry 60 (23) (2021)
Steffen Bayerschmidt, Christian Uprimny, Alexander Stephan Kroiss, Josef Fritz, Bernhard Nilica, Hanna Svirydenka, Clemens Decristoforo, Elisabeth von Guggenberg, Wolfgang Horninger, Irene Johanna Virgolini
Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT. Diagnostics (Basel, Switzerland) 11 (7) (2021)
Matthias Misslinger, Milos Petrik, Joachim Pfister, Isabella Hubmann, Katerina Bendova, Clemens Decristoforo, Hubertus Haas
Desferrioxamine B-Mediated Pre-Clinical In Vivo Imaging of Infection by the Mold Fungus Aspergillus fumigatus. Journal of fungi (Basel, Switzerland) 7 (9) (2021)
Dominik Summer, Milos Petrik, Sonja Mayr, Martin Hermann, Piriya Kaeopookum, Joachim Pfister, Maximilian Klingler, Christine Rangger, Hubertus Haas, Clemens Decristoforo
Hybrid Imaging Agents for Pretargeting Applications Based on Fusarinine C-Proof of Concept. Molecules (Basel, Switzerland) 25 (9) (2020)
Melpomeni Fani, Viktoria Weingaertner, Petra Kolenc, Rosalba Mansi, Raghuvir H Gaonkar, Piotr Garnuszek, Renata Mikolajczak, Doroteja Novak, Urban Simoncic, Alicja Hubalewska-Dydejczyk, Christine Rangger, Piriya Kaeopookum, Clemens Decristoforo
Selection of the First 99mTc-Labelled Somatostatin Receptor Subtype 2 Antagonist for Clinical Translation-Preclinical Assessment of Two Optimized Candidates. Pharmaceuticals (Basel, Switzerland) 14 (1) (2020)
Milos Petrik, Joachim Pfister, Matthias Misslinger, Clemens Decristoforo, Hubertus Haas
Siderophore-Based Molecular Imaging of Fungal and Bacterial Infections-Current Status and Future Perspectives. Journal of fungi (Basel, Switzerland) 6 (2) (2020)
Piriya Kaeopookum, Dominik Summer, Joachim Pfister, Thomas Orasch, Beatrix E Lechner, Milos Petrik, Zbynek Novy, Barbara Matuszczak, Christine Rangger, Hubertus Haas, Clemens Decristoforo
Modifying the Siderophore Triacetylfusarinine C for Molecular Imaging of Fungal Infection. Molecular imaging and biology 21 (6) (2020)
Joachim Pfister, Roland Bata, Isabella Hubmann, Anton Amadeus Hörmann, Fabio Gsaller, Hubertus Haas, Clemens Decristoforo
Siderophore Scaffold as Carrier for Antifungal Peptides in Therapy of Aspergillus fumigatus Infections. Journal of fungi (Basel, Switzerland) 6 (4) (2020)
Chuangyan Zhai, Shanzhen He, Yunjie Ye, Christine Rangger, Piriya Kaeopookum, Dominik Summer, Hubertus Haas, Leopold Kremser, Herbert Lindner, Julie Foster, Jane Sosabowski, Clemens Decristoforo
Rational Design, Synthesis and Preliminary Evaluation of Novel Fusarinine C-Based Chelators for Radiolabeling with Zirconium-89. Biomolecules 9 (3) (2019)
Petra Kolenc Peitl, Christine Rangger, Piotr Garnuszek, Renata Mikolajczak, Alicja Hubalewska-Dydejczyk, Theodosia Maina, Paola Erba, Clemens Decristoforo
Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples. Journal of labelled compounds & radiopharmaceuticals 62 (10) (2019)
Maximilian Klingler, Christine Rangger, Dominik Summer, Piriya Kaeopookum, Clemens Decristoforo, Elisabeth von Guggenberg
Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13. Pharmaceuticals (Basel, Switzerland) 12 (2) (2019)
Maximilian Klingler, Christine Rangger, Dominik Summer, Piriya Kaeopookum, Clemens Decristoforo, Elisabeth von Guggenberg
Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals (Basel, Switzerland) 12 (1) (2019)
Sally W Schwarz, Clemens Decristoforo
US and EU radiopharmaceutical diagnostic and therapeutic nonclinical study requirements for clinical trials authorizations and marketing authorizations. EJNMMI radiopharmacy and chemistry 4 (1) (2019)
D Haeusler, Clemens Decristoforo, J Frost, S Gobalakrishnan, Ya-Yao Huang
Molecular Imaging: In Vivo Agents for the Diagnosis and Treatment of Cancer. Contrast media & molecular imaging 2018 (2018)
Dominik Summer, Sonja Mayr, Milos Petrik, Christine Rangger, Katia Schoeler, Lisa Vieider, Barbara Matuszczak, Clemens Decristoforo
Pretargeted Imaging with Gallium-68-Improving the Binding Capability by Increasing the Number of Tetrazine Motifs. Pharmaceuticals (Basel, Switzerland) 11 (4) (2018)
Alicia Vall-Sagarra, Shanna Litau, Clemens Decristoforo, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler
Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y₁)- and GRP-Receptors-An Improvement for Breast Cancer Imaging? Pharmaceuticals (Basel, Switzerland) 11 (3) (2018)
Dominik Summer, Christine Rangger, Maximilian Klingler, Peter Laverman, Gerben M Franssen, Beatrix E Lechner, Thomas Orasch, Hubertus Haas, Elisabeth von Guggenberg, Clemens Decristoforo
Exploiting the Concept of Multivalency with 68Ga- and 89Zr-Labelled Fusarinine C-Minigastrin Bioconjugates for Targeting CCK2R Expression. Contrast media & molecular imaging 2018 (2018)
Dominik Summer, Andrea Kroess, Rudolf Woerndle, Christine Rangger, Maximilian Klingler, Hubertus Haas, Leopold Kremser, Herbert H Lindner, Elisabeth von Guggenberg, Clemens Decristoforo
Multimerization results in formation of re-bindable metabolites: A proof of concept study with FSC-based minigastrin imaging probes targeting CCK2R expression. PloS one 13 (7) (2018)
Stefano Fanti, Rachele Bonfiglioli, Clemens Decristoforo
Highlights of the 30th Annual Congress of the EANM, Vienna 2017: "Yes we can - make nuclear medicine great again". European journal of nuclear medicine and molecular imaging 45 (10) (2018)
Dominik Summer, Leo Grossrubatscher, Milos Petrik, Tereza Michalcikova, Zbynek Novy, Christine Rangger, Maximilian Klingler, Hubertus Haas, Piriya Kaeopookum, Elisabeth von Guggenberg, Roland Haubner, Clemens Decristoforo
Developing Targeted Hybrid Imaging Probes by Chelator Scaffolding. Bioconjugate chemistry 28 (6) (2017)
Dominik Summer, Javad Garousi, Maryam Oroujeni, Bogdan Mitran, Ken G Andersson, Anzhelika Vorobyeva, John Löfblom, Anna Orlova, Vladimir Tolmachev, Clemens Decristoforo
Cyclic versus Noncyclic Chelating Scaffold for 89Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression. Molecular pharmaceutics 15 (1) (2017)
Milos Petrik, Chuangyan Zhai, Hubertus Haas, Clemens Decristoforo
Siderophores for molecular imaging applications. Clinical and translational imaging 5 (1) (2016)
Joachim Pfister, Dominik Summer, Christine Rangger, Milos Petrik, Elisabeth von Guggenberg, Paolo Minazzi, Giovanni B Giovenzana, Luigi Aloj, Clemens Decristoforo
Influence of a novel, versatile bifunctional chelator on theranostic properties of a minigastrin analogue. EJNMMI research 5 (1) (2015)

Clemens Decristoforo.css-eqlu8i{font-size:small;padding-left:4px;} (C Decristoforo)

Publication Activity (10 Years)

Top Topics

Top Venues

Clemens Decristoforo (C Decristoforo)